nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—DDC—renal system—uterine cancer	0.0152	0.0622	CbGeAlD
Methyldopa—COMT—myometrium—uterine cancer	0.0138	0.0565	CbGeAlD
Methyldopa—SLC15A1—epithelium—uterine cancer	0.0122	0.0499	CbGeAlD
Methyldopa—DDC—female reproductive system—uterine cancer	0.0122	0.0498	CbGeAlD
Methyldopa—SLC15A1—renal system—uterine cancer	0.0113	0.0463	CbGeAlD
Methyldopa—SLC15A1—endometrium—uterine cancer	0.0109	0.0447	CbGeAlD
Methyldopa—COMT—uterine cervix—uterine cancer	0.0107	0.044	CbGeAlD
Methyldopa—SLC15A1—mammalian vulva—uterine cancer	0.0106	0.0433	CbGeAlD
Methyldopa—COMT—smooth muscle tissue—uterine cancer	0.0104	0.0427	CbGeAlD
Methyldopa—COMT—decidua—uterine cancer	0.0102	0.0419	CbGeAlD
Methyldopa—COMT—renal system—uterine cancer	0.01	0.0411	CbGeAlD
Methyldopa—Myocarditis—Epirubicin—uterine cancer	0.00991	0.0131	CcSEcCtD
Methyldopa—COMT—endometrium—uterine cancer	0.0097	0.0398	CbGeAlD
Methyldopa—Tenderness—Progesterone—uterine cancer	0.00967	0.0128	CcSEcCtD
Methyldopa—Amenorrhoea—Progesterone—uterine cancer	0.0096	0.0127	CcSEcCtD
Methyldopa—COMT—mammalian vulva—uterine cancer	0.00939	0.0385	CbGeAlD
Methyldopa—Endocrine disorder—Medroxyprogesterone Acetate—uterine cancer	0.00922	0.0122	CcSEcCtD
Methyldopa—Myocarditis—Doxorubicin—uterine cancer	0.00917	0.0121	CcSEcCtD
Methyldopa—COMT—uterus—uterine cancer	0.00894	0.0367	CbGeAlD
Methyldopa—Tenderness—Medroxyprogesterone Acetate—uterine cancer	0.00876	0.0116	CcSEcCtD
Methyldopa—Amenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0087	0.0115	CcSEcCtD
Methyldopa—Hepatocellular injury—Progesterone—uterine cancer	0.00844	0.0112	CcSEcCtD
Methyldopa—SLC15A1—vagina—uterine cancer	0.00817	0.0335	CbGeAlD
Methyldopa—COMT—female reproductive system—uterine cancer	0.00804	0.033	CbGeAlD
Methyldopa—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.00764	0.0101	CcSEcCtD
Methyldopa—Lightheadedness—Progesterone—uterine cancer	0.00755	0.00998	CcSEcCtD
Methyldopa—COMT—female gonad—uterine cancer	0.00732	0.03	CbGeAlD
Methyldopa—COMT—vagina—uterine cancer	0.00727	0.0298	CbGeAlD
Methyldopa—DDC—lymph node—uterine cancer	0.00711	0.0292	CbGeAlD
Methyldopa—ADRA2A—myometrium—uterine cancer	0.00702	0.0288	CbGeAlD
Methyldopa—Nasal congestion—Progesterone—uterine cancer	0.00672	0.00889	CcSEcCtD
Methyldopa—Libido decreased—Progesterone—uterine cancer	0.0066	0.00873	CcSEcCtD
Methyldopa—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00615	0.00813	CcSEcCtD
Methyldopa—Cardiac failure congestive—Medroxyprogesterone Acetate—uterine cancer	0.00612	0.00809	CcSEcCtD
Methyldopa—Disturbance in sexual arousal—Progesterone—uterine cancer	0.00607	0.00804	CcSEcCtD
Methyldopa—Libido decreased—Medroxyprogesterone Acetate—uterine cancer	0.00598	0.00791	CcSEcCtD
Methyldopa—Infection—Carboplatin—uterine cancer	0.00569	0.00753	CcSEcCtD
Methyldopa—Liver function test abnormal—Progesterone—uterine cancer	0.00565	0.00748	CcSEcCtD
Methyldopa—Pericarditis—Epirubicin—uterine cancer	0.00559	0.0074	CcSEcCtD
Methyldopa—Breast disorder—Progesterone—uterine cancer	0.00553	0.00732	CcSEcCtD
Methyldopa—Disturbance in sexual arousal—Medroxyprogesterone Acetate—uterine cancer	0.0055	0.00728	CcSEcCtD
Methyldopa—ADRA2A—uterine cervix—uterine cancer	0.00546	0.0224	CbGeAlD
Methyldopa—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.00542	0.00717	CcSEcCtD
Methyldopa—Abdominal distension—Progesterone—uterine cancer	0.00533	0.00705	CcSEcCtD
Methyldopa—ADRA2A—decidua—uterine cancer	0.00521	0.0213	CbGeAlD
Methyldopa—Pericarditis—Doxorubicin—uterine cancer	0.00517	0.00684	CcSEcCtD
Methyldopa—Angina pectoris—Progesterone—uterine cancer	0.00516	0.00682	CcSEcCtD
Methyldopa—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00507	0.0067	CcSEcCtD
Methyldopa—Breast disorder—Medroxyprogesterone Acetate—uterine cancer	0.00501	0.00663	CcSEcCtD
Methyldopa—ADRA2A—endometrium—uterine cancer	0.00494	0.0203	CbGeAlD
Methyldopa—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.00483	0.00639	CcSEcCtD
Methyldopa—Weight increased—Progesterone—uterine cancer	0.00482	0.00637	CcSEcCtD
Methyldopa—ADRA2A—mammalian vulva—uterine cancer	0.00478	0.0196	CbGeAlD
Methyldopa—Infestation—Progesterone—uterine cancer	0.00472	0.00624	CcSEcCtD
Methyldopa—Infestation NOS—Progesterone—uterine cancer	0.00472	0.00624	CcSEcCtD
Methyldopa—COMT—lymph node—uterine cancer	0.0047	0.0193	CbGeAlD
Methyldopa—Jaundice—Progesterone—uterine cancer	0.0046	0.00608	CcSEcCtD
Methyldopa—ADRA2A—uterus—uterine cancer	0.00455	0.0187	CbGeAlD
Methyldopa—Body temperature increased—Carboplatin—uterine cancer	0.00453	0.00599	CcSEcCtD
Methyldopa—Hepatobiliary disease—Progesterone—uterine cancer	0.00446	0.0059	CcSEcCtD
Methyldopa—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.00436	0.00577	CcSEcCtD
Methyldopa—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.00428	0.00566	CcSEcCtD
Methyldopa—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.00428	0.00566	CcSEcCtD
Methyldopa—Hepatitis—Progesterone—uterine cancer	0.00424	0.0056	CcSEcCtD
Methyldopa—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00417	0.00551	CcSEcCtD
Methyldopa—Connective tissue disorder—Progesterone—uterine cancer	0.00416	0.00551	CcSEcCtD
Methyldopa—ADRA2A—female reproductive system—uterine cancer	0.00409	0.0168	CbGeAlD
Methyldopa—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00404	0.00535	CcSEcCtD
Methyldopa—Liver function test abnormal—Dactinomycin—uterine cancer	0.004	0.00529	CcSEcCtD
Methyldopa—Cardiac disorder—Progesterone—uterine cancer	0.00393	0.0052	CcSEcCtD
Methyldopa—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00391	0.00517	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.0039	0.00515	CcSEcCtD
Methyldopa—Angiopathy—Progesterone—uterine cancer	0.00384	0.00508	CcSEcCtD
Methyldopa—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00384	0.00508	CcSEcCtD
Methyldopa—Mediastinal disorder—Progesterone—uterine cancer	0.00382	0.00505	CcSEcCtD
Methyldopa—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00377	0.00499	CcSEcCtD
Methyldopa—ADRA2A—female gonad—uterine cancer	0.00373	0.0153	CbGeAlD
Methyldopa—Mental disorder—Progesterone—uterine cancer	0.00371	0.00491	CcSEcCtD
Methyldopa—ADRA2A—vagina—uterine cancer	0.0037	0.0152	CbGeAlD
Methyldopa—Flatulence—Progesterone—uterine cancer	0.00363	0.00481	CcSEcCtD
Methyldopa—Bone marrow depression—Epirubicin—uterine cancer	0.00358	0.00474	CcSEcCtD
Methyldopa—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00356	0.00471	CcSEcCtD
Methyldopa—Pancytopenia—Dactinomycin—uterine cancer	0.00355	0.0047	CcSEcCtD
Methyldopa—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00348	0.00461	CcSEcCtD
Methyldopa—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00346	0.00458	CcSEcCtD
Methyldopa—Cardiac failure congestive—Etoposide—uterine cancer	0.00345	0.00457	CcSEcCtD
Methyldopa—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00336	0.00445	CcSEcCtD
Methyldopa—Bone marrow depression—Doxorubicin—uterine cancer	0.00332	0.00439	CcSEcCtD
Methyldopa—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00329	0.00436	CcSEcCtD
Methyldopa—Myalgia—Progesterone—uterine cancer	0.00314	0.00415	CcSEcCtD
Methyldopa—Arthralgia—Progesterone—uterine cancer	0.00314	0.00415	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00312	0.00412	CcSEcCtD
Methyldopa—Agranulocytosis—Dactinomycin—uterine cancer	0.00311	0.00412	CcSEcCtD
Methyldopa—Oedema—Progesterone—uterine cancer	0.00301	0.00398	CcSEcCtD
Methyldopa—Hepatitis—Dactinomycin—uterine cancer	0.00299	0.00396	CcSEcCtD
Methyldopa—Infection—Progesterone—uterine cancer	0.00299	0.00395	CcSEcCtD
Methyldopa—Nervous system disorder—Progesterone—uterine cancer	0.00295	0.0039	CcSEcCtD
Methyldopa—Skin disorder—Progesterone—uterine cancer	0.00292	0.00387	CcSEcCtD
Methyldopa—Liver injury—Epirubicin—uterine cancer	0.00287	0.0038	CcSEcCtD
Methyldopa—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.00376	CcSEcCtD
Methyldopa—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.00376	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00283	0.00374	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00282	0.00373	CcSEcCtD
Methyldopa—Amenorrhoea—Epirubicin—uterine cancer	0.00275	0.00364	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00274	0.00363	CcSEcCtD
Methyldopa—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.00361	CcSEcCtD
Methyldopa—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00271	0.00358	CcSEcCtD
Methyldopa—Paraesthesia—Progesterone—uterine cancer	0.0027	0.00357	CcSEcCtD
Methyldopa—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00267	0.00354	CcSEcCtD
Methyldopa—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00267	0.00353	CcSEcCtD
Methyldopa—Liver injury—Doxorubicin—uterine cancer	0.00266	0.00352	CcSEcCtD
Methyldopa—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00265	0.0035	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Progesterone—uterine cancer	0.0026	0.00344	CcSEcCtD
Methyldopa—Constipation—Progesterone—uterine cancer	0.00257	0.0034	CcSEcCtD
Methyldopa—Pancytopenia—Etoposide—uterine cancer	0.00257	0.0034	CcSEcCtD
Methyldopa—Amenorrhoea—Doxorubicin—uterine cancer	0.00255	0.00337	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00248	0.00329	CcSEcCtD
Methyldopa—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00245	0.00324	CcSEcCtD
Methyldopa—Hepatocellular injury—Epirubicin—uterine cancer	0.00242	0.0032	CcSEcCtD
Methyldopa—Infestation NOS—Etoposide—uterine cancer	0.00241	0.00319	CcSEcCtD
Methyldopa—Infestation—Etoposide—uterine cancer	0.00241	0.00319	CcSEcCtD
Methyldopa—ADRA2A—lymph node—uterine cancer	0.00239	0.00982	CbGeAlD
Methyldopa—Body temperature increased—Progesterone—uterine cancer	0.00238	0.00315	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.00311	CcSEcCtD
Methyldopa—Jaundice—Etoposide—uterine cancer	0.00235	0.00311	CcSEcCtD
Methyldopa—Leukopenia—Dactinomycin—uterine cancer	0.00233	0.00309	CcSEcCtD
Methyldopa—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00233	0.00308	CcSEcCtD
Methyldopa—Colitis—Epirubicin—uterine cancer	0.00232	0.00307	CcSEcCtD
Methyldopa—Hepatobiliary disease—Etoposide—uterine cancer	0.00228	0.00302	CcSEcCtD
Methyldopa—Agranulocytosis—Etoposide—uterine cancer	0.00225	0.00298	CcSEcCtD
Methyldopa—Hepatocellular injury—Doxorubicin—uterine cancer	0.00224	0.00296	CcSEcCtD
Methyldopa—Myalgia—Dactinomycin—uterine cancer	0.00222	0.00294	CcSEcCtD
Methyldopa—Hypersensitivity—Progesterone—uterine cancer	0.00222	0.00293	CcSEcCtD
Methyldopa—Asthenia—Progesterone—uterine cancer	0.00216	0.00286	CcSEcCtD
Methyldopa—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.00285	CcSEcCtD
Methyldopa—Colitis—Doxorubicin—uterine cancer	0.00215	0.00284	CcSEcCtD
Methyldopa—Oedema—Dactinomycin—uterine cancer	0.00213	0.00281	CcSEcCtD
Methyldopa—Infection—Dactinomycin—uterine cancer	0.00211	0.0028	CcSEcCtD
Methyldopa—Thrombocytopenia—Dactinomycin—uterine cancer	0.00208	0.00275	CcSEcCtD
Methyldopa—Diarrhoea—Progesterone—uterine cancer	0.00206	0.00272	CcSEcCtD
Methyldopa—Cardiac disorder—Etoposide—uterine cancer	0.00201	0.00266	CcSEcCtD
Methyldopa—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00201	0.00266	CcSEcCtD
Methyldopa—Dizziness—Progesterone—uterine cancer	0.00199	0.00263	CcSEcCtD
Methyldopa—Angiopathy—Etoposide—uterine cancer	0.00197	0.0026	CcSEcCtD
Methyldopa—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.00259	CcSEcCtD
Methyldopa—Eczema—Epirubicin—uterine cancer	0.00195	0.00258	CcSEcCtD
Methyldopa—Mediastinal disorder—Etoposide—uterine cancer	0.00195	0.00258	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00194	0.00256	CcSEcCtD
Methyldopa—Cardiac failure congestive—Epirubicin—uterine cancer	0.00194	0.00256	CcSEcCtD
Methyldopa—Vomiting—Progesterone—uterine cancer	0.00191	0.00253	CcSEcCtD
Methyldopa—Rash—Progesterone—uterine cancer	0.0019	0.00251	CcSEcCtD
Methyldopa—Dermatitis—Progesterone—uterine cancer	0.0019	0.00251	CcSEcCtD
Methyldopa—Headache—Progesterone—uterine cancer	0.00189	0.00249	CcSEcCtD
Methyldopa—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00187	0.00247	CcSEcCtD
Methyldopa—Eczema—Doxorubicin—uterine cancer	0.00181	0.00239	CcSEcCtD
Methyldopa—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00239	CcSEcCtD
Methyldopa—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00179	0.00237	CcSEcCtD
Methyldopa—Nausea—Progesterone—uterine cancer	0.00179	0.00236	CcSEcCtD
Methyldopa—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00229	CcSEcCtD
Methyldopa—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00227	CcSEcCtD
Methyldopa—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00227	CcSEcCtD
Methyldopa—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00226	CcSEcCtD
Methyldopa—Leukopenia—Etoposide—uterine cancer	0.00169	0.00223	CcSEcCtD
Methyldopa—Body temperature increased—Dactinomycin—uterine cancer	0.00168	0.00222	CcSEcCtD
Methyldopa—Liver function test abnormal—Epirubicin—uterine cancer	0.00162	0.00214	CcSEcCtD
Methyldopa—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.00214	CcSEcCtD
Methyldopa—Orthostatic hypotension—Epirubicin—uterine cancer	0.0016	0.00212	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00159	0.00211	CcSEcCtD
Methyldopa—Breast disorder—Epirubicin—uterine cancer	0.00159	0.0021	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00158	0.00209	CcSEcCtD
Methyldopa—Hypersensitivity—Dactinomycin—uterine cancer	0.00157	0.00207	CcSEcCtD
Methyldopa—Infection—Etoposide—uterine cancer	0.00153	0.00202	CcSEcCtD
Methyldopa—Abdominal distension—Epirubicin—uterine cancer	0.00153	0.00202	CcSEcCtD
Methyldopa—Asthenia—Dactinomycin—uterine cancer	0.00153	0.00202	CcSEcCtD
Methyldopa—Thrombocytopenia—Etoposide—uterine cancer	0.00151	0.00199	CcSEcCtD
Methyldopa—Eosinophilia—Epirubicin—uterine cancer	0.0015	0.00199	CcSEcCtD
Methyldopa—Liver function test abnormal—Doxorubicin—uterine cancer	0.0015	0.00198	CcSEcCtD
Methyldopa—Skin disorder—Etoposide—uterine cancer	0.0015	0.00198	CcSEcCtD
Methyldopa—Pancreatitis—Epirubicin—uterine cancer	0.00149	0.00197	CcSEcCtD
Methyldopa—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00148	0.00196	CcSEcCtD
Methyldopa—Angina pectoris—Epirubicin—uterine cancer	0.00148	0.00196	CcSEcCtD
Methyldopa—Breast disorder—Doxorubicin—uterine cancer	0.00147	0.00194	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00146	0.00194	CcSEcCtD
Methyldopa—Diarrhoea—Dactinomycin—uterine cancer	0.00146	0.00193	CcSEcCtD
Methyldopa—Pancytopenia—Epirubicin—uterine cancer	0.00144	0.00191	CcSEcCtD
Methyldopa—Abdominal distension—Doxorubicin—uterine cancer	0.00141	0.00187	CcSEcCtD
Methyldopa—Eosinophilia—Doxorubicin—uterine cancer	0.00139	0.00184	CcSEcCtD
Methyldopa—Paraesthesia—Etoposide—uterine cancer	0.00138	0.00183	CcSEcCtD
Methyldopa—Weight increased—Epirubicin—uterine cancer	0.00138	0.00183	CcSEcCtD
Methyldopa—Pancreatitis—Doxorubicin—uterine cancer	0.00138	0.00182	CcSEcCtD
Methyldopa—Angina pectoris—Doxorubicin—uterine cancer	0.00137	0.00181	CcSEcCtD
Methyldopa—Infestation NOS—Epirubicin—uterine cancer	0.00135	0.00179	CcSEcCtD
Methyldopa—Infestation—Epirubicin—uterine cancer	0.00135	0.00179	CcSEcCtD
Methyldopa—Vomiting—Dactinomycin—uterine cancer	0.00135	0.00179	CcSEcCtD
Methyldopa—Rash—Dactinomycin—uterine cancer	0.00134	0.00177	CcSEcCtD
Methyldopa—Pancytopenia—Doxorubicin—uterine cancer	0.00133	0.00176	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Etoposide—uterine cancer	0.00133	0.00176	CcSEcCtD
Methyldopa—Jaundice—Epirubicin—uterine cancer	0.00132	0.00174	CcSEcCtD
Methyldopa—Constipation—Etoposide—uterine cancer	0.00132	0.00174	CcSEcCtD
Methyldopa—Hepatobiliary disease—Epirubicin—uterine cancer	0.00128	0.00169	CcSEcCtD
Methyldopa—Weight increased—Doxorubicin—uterine cancer	0.00128	0.00169	CcSEcCtD
Methyldopa—Nausea—Dactinomycin—uterine cancer	0.00126	0.00167	CcSEcCtD
Methyldopa—Agranulocytosis—Epirubicin—uterine cancer	0.00126	0.00167	CcSEcCtD
Methyldopa—Infestation—Doxorubicin—uterine cancer	0.00125	0.00166	CcSEcCtD
Methyldopa—Infestation NOS—Doxorubicin—uterine cancer	0.00125	0.00166	CcSEcCtD
Methyldopa—Bradycardia—Epirubicin—uterine cancer	0.00124	0.00164	CcSEcCtD
Methyldopa—Jaundice—Doxorubicin—uterine cancer	0.00122	0.00161	CcSEcCtD
Methyldopa—Body temperature increased—Etoposide—uterine cancer	0.00122	0.00161	CcSEcCtD
Methyldopa—Hepatitis—Epirubicin—uterine cancer	0.00121	0.00161	CcSEcCtD
Methyldopa—Connective tissue disorder—Epirubicin—uterine cancer	0.00119	0.00158	CcSEcCtD
Methyldopa—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00118	0.00157	CcSEcCtD
Methyldopa—Agranulocytosis—Doxorubicin—uterine cancer	0.00117	0.00155	CcSEcCtD
Methyldopa—Bradycardia—Doxorubicin—uterine cancer	0.00114	0.00151	CcSEcCtD
Methyldopa—Hypersensitivity—Etoposide—uterine cancer	0.00113	0.0015	CcSEcCtD
Methyldopa—Cardiac disorder—Epirubicin—uterine cancer	0.00113	0.00149	CcSEcCtD
Methyldopa—Hepatitis—Doxorubicin—uterine cancer	0.00112	0.00149	CcSEcCtD
Methyldopa—Asthenia—Etoposide—uterine cancer	0.0011	0.00146	CcSEcCtD
Methyldopa—Connective tissue disorder—Doxorubicin—uterine cancer	0.0011	0.00146	CcSEcCtD
Methyldopa—Angiopathy—Epirubicin—uterine cancer	0.0011	0.00146	CcSEcCtD
Methyldopa—Mediastinal disorder—Epirubicin—uterine cancer	0.00109	0.00145	CcSEcCtD
Methyldopa—Mental disorder—Epirubicin—uterine cancer	0.00106	0.00141	CcSEcCtD
Methyldopa—Diarrhoea—Etoposide—uterine cancer	0.00105	0.00139	CcSEcCtD
Methyldopa—Cardiac disorder—Doxorubicin—uterine cancer	0.00104	0.00138	CcSEcCtD
Methyldopa—Flatulence—Epirubicin—uterine cancer	0.00104	0.00138	CcSEcCtD
Methyldopa—Angiopathy—Doxorubicin—uterine cancer	0.00102	0.00135	CcSEcCtD
Methyldopa—Dizziness—Etoposide—uterine cancer	0.00102	0.00135	CcSEcCtD
Methyldopa—Mediastinal disorder—Doxorubicin—uterine cancer	0.00101	0.00134	CcSEcCtD
Methyldopa—Mental disorder—Doxorubicin—uterine cancer	0.000985	0.0013	CcSEcCtD
Methyldopa—Vomiting—Etoposide—uterine cancer	0.000979	0.00129	CcSEcCtD
Methyldopa—Rash—Etoposide—uterine cancer	0.000971	0.00128	CcSEcCtD
Methyldopa—Dermatitis—Etoposide—uterine cancer	0.00097	0.00128	CcSEcCtD
Methyldopa—Headache—Etoposide—uterine cancer	0.000964	0.00128	CcSEcCtD
Methyldopa—Flatulence—Doxorubicin—uterine cancer	0.000964	0.00128	CcSEcCtD
Methyldopa—Leukopenia—Epirubicin—uterine cancer	0.000947	0.00125	CcSEcCtD
Methyldopa—Nausea—Etoposide—uterine cancer	0.000914	0.00121	CcSEcCtD
Methyldopa—Myalgia—Epirubicin—uterine cancer	0.0009	0.00119	CcSEcCtD
Methyldopa—Arthralgia—Epirubicin—uterine cancer	0.0009	0.00119	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000894	0.00118	CcSEcCtD
Methyldopa—Leukopenia—Doxorubicin—uterine cancer	0.000876	0.00116	CcSEcCtD
Methyldopa—Oedema—Epirubicin—uterine cancer	0.000863	0.00114	CcSEcCtD
Methyldopa—Infection—Epirubicin—uterine cancer	0.000857	0.00113	CcSEcCtD
Methyldopa—Nervous system disorder—Epirubicin—uterine cancer	0.000846	0.00112	CcSEcCtD
Methyldopa—Thrombocytopenia—Epirubicin—uterine cancer	0.000845	0.00112	CcSEcCtD
Methyldopa—Skin disorder—Epirubicin—uterine cancer	0.000838	0.00111	CcSEcCtD
Methyldopa—Myalgia—Doxorubicin—uterine cancer	0.000833	0.0011	CcSEcCtD
Methyldopa—Arthralgia—Doxorubicin—uterine cancer	0.000833	0.0011	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000827	0.00109	CcSEcCtD
Methyldopa—Oedema—Doxorubicin—uterine cancer	0.000799	0.00106	CcSEcCtD
Methyldopa—Infection—Doxorubicin—uterine cancer	0.000793	0.00105	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000786	0.00104	CcSEcCtD
Methyldopa—Nervous system disorder—Doxorubicin—uterine cancer	0.000783	0.00104	CcSEcCtD
Methyldopa—Thrombocytopenia—Doxorubicin—uterine cancer	0.000782	0.00103	CcSEcCtD
Methyldopa—Skin disorder—Doxorubicin—uterine cancer	0.000776	0.00103	CcSEcCtD
Methyldopa—Paraesthesia—Epirubicin—uterine cancer	0.000775	0.00102	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000745	0.000985	CcSEcCtD
Methyldopa—Constipation—Epirubicin—uterine cancer	0.000738	0.000976	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000727	0.000962	CcSEcCtD
Methyldopa—Paraesthesia—Doxorubicin—uterine cancer	0.000717	0.000948	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000689	0.000912	CcSEcCtD
Methyldopa—Constipation—Doxorubicin—uterine cancer	0.000683	0.000903	CcSEcCtD
Methyldopa—Body temperature increased—Epirubicin—uterine cancer	0.000682	0.000902	CcSEcCtD
Methyldopa—Hypersensitivity—Epirubicin—uterine cancer	0.000636	0.000841	CcSEcCtD
Methyldopa—Body temperature increased—Doxorubicin—uterine cancer	0.000631	0.000835	CcSEcCtD
Methyldopa—Asthenia—Epirubicin—uterine cancer	0.000619	0.000819	CcSEcCtD
Methyldopa—Diarrhoea—Epirubicin—uterine cancer	0.00059	0.000781	CcSEcCtD
Methyldopa—Hypersensitivity—Doxorubicin—uterine cancer	0.000588	0.000778	CcSEcCtD
Methyldopa—Asthenia—Doxorubicin—uterine cancer	0.000573	0.000758	CcSEcCtD
Methyldopa—Dizziness—Epirubicin—uterine cancer	0.000571	0.000755	CcSEcCtD
Methyldopa—Vomiting—Epirubicin—uterine cancer	0.000549	0.000726	CcSEcCtD
Methyldopa—Diarrhoea—Doxorubicin—uterine cancer	0.000546	0.000723	CcSEcCtD
Methyldopa—Rash—Epirubicin—uterine cancer	0.000544	0.00072	CcSEcCtD
Methyldopa—Dermatitis—Epirubicin—uterine cancer	0.000544	0.000719	CcSEcCtD
Methyldopa—Headache—Epirubicin—uterine cancer	0.000541	0.000715	CcSEcCtD
Methyldopa—Dizziness—Doxorubicin—uterine cancer	0.000528	0.000698	CcSEcCtD
Methyldopa—Nausea—Epirubicin—uterine cancer	0.000513	0.000678	CcSEcCtD
Methyldopa—Vomiting—Doxorubicin—uterine cancer	0.000508	0.000672	CcSEcCtD
Methyldopa—Rash—Doxorubicin—uterine cancer	0.000503	0.000666	CcSEcCtD
Methyldopa—Dermatitis—Doxorubicin—uterine cancer	0.000503	0.000665	CcSEcCtD
Methyldopa—Headache—Doxorubicin—uterine cancer	0.0005	0.000662	CcSEcCtD
Methyldopa—Nausea—Doxorubicin—uterine cancer	0.000474	0.000627	CcSEcCtD
